Toronto, Ontario and Chicago, Illinois--(Newsfile Corp. - March 14, 2025) - Medexus Pharmaceuticals (TSX: MDP) (OTCQX: MEDXF) recently completed an agreement with NX Development Corp., the licensor of ...
LEXINGTON, KENTUCKY / ACCESS Newswire / April 24, 2025 / Today, NX Development Corp ("NXDC"), a Lexington, KY based life sciences company, announced the return of the sales and marketing rights for ...
Medexus Pharmaceuticals, a leading specialty pharmaceutical company with a strong North American commercial platform and a growing portfolio of innovative and rare disease treatment solutions, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback